Adventure

Dassault Systmes: declaration of the number of outstanding shares and voting rights as of May 31, 2025

Press ReleaseVELIZY-VILLACOUBLAY, France — June 9, 2025                 Declaration of the number of outstanding shares and voting rights as of May…

7 months ago

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full…

7 months ago

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025 16:01 ET  | Source: Replimune Group Inc WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group,…

7 months ago

Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference

June 06, 2025 16:01 ET  | Source: Keros Therapeutics, Inc. LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics,…

7 months ago

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

June 06, 2025 16:00 ET  | Source: Zealand Pharma Company announcement – No. 14 / 2025 Zealand Pharma increases its…

7 months ago

Now Boarding: Metro’s LAX/Metro Transit Center Station Officially Opens, Connecting Communities; Bringing Faster, Easier Travel for Angelenos, Visitors

New Station Sets Stage for Metro, Los Angeles to Welcome World to FIFA World Cup 2026™, Super Bowl LXI, 2028…

7 months ago

RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress

June 06, 2025 16:07 ET  | Source: Restem MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology…

7 months ago

Enovis to Participate in Upcoming Investor Conferences

June 06, 2025 16:05 ET  | Source: Enovis Corporation Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:…

7 months ago

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025 16:05 ET  | Source: TELA Bio, Inc. MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…

7 months ago

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

June 06, 2025 16:05 ET  | Source: PolyPid Ltd. PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD),…

7 months ago